CN Stock MarketDetailed Quotes

688319 Chengdu Olymvax Biopharmaceuticals Inc

Watchlist
  • 10.36
  • +0.32+3.19%
Market Closed Nov 19 15:00 CST
4.21BMarket Cap-493333P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.75%386.65M
-2.97%226.28M
5.87%70.8M
-9.38%496.12M
-4.98%352.3M
0.21%233.2M
24.91%66.87M
12.38%547.48M
30.20%370.78M
37.60%232.71M
Operating revenue
9.75%386.65M
-2.97%226.28M
5.87%70.8M
-9.38%496.12M
-4.98%352.3M
0.21%233.2M
24.91%66.87M
12.38%547.48M
30.20%370.78M
37.60%232.71M
Total operating cost
15.50%379.82M
24.47%244.5M
71.43%109.13M
-5.24%490.85M
4.16%328.85M
5.47%196.44M
3.41%63.66M
34.39%517.97M
48.28%315.7M
47.24%186.25M
Operating cost
-18.54%20.43M
-24.15%12.3M
-25.14%5.36M
-18.09%32M
-7.78%25.07M
-7.07%16.22M
146.53%7.16M
32.05%39.06M
28.02%27.19M
41.80%17.45M
Operating tax surcharges
6.43%2.23M
-4.17%1.6M
3.60%402.43K
-6.41%3.32M
-6.08%2.09M
1.31%1.67M
17.89%388.44K
10.67%3.55M
23.76%2.23M
23.15%1.65M
Operating expense
15.55%185.24M
0.52%102.82M
-14.35%23.92M
-10.61%257.81M
-5.07%160.31M
-0.98%102.29M
1.71%27.93M
17.47%288.39M
38.38%168.87M
55.23%103.3M
Administration expense
8.40%63.04M
41.57%46.87M
231.47%29.43M
23.01%78.31M
25.85%58.16M
5.23%33.11M
-37.30%8.88M
25.26%63.66M
33.74%46.21M
35.94%31.47M
Financial expense
223.52%9.48M
255.47%5.62M
247.42%2.28M
257.23%4.68M
181.32%2.93M
89.18%1.58M
98.56%655.18K
2,286.90%1.31M
3,793.86%1.04M
90.11%835.37K
-Interest expense (Financial expense)
128.58%10.38M
122.95%6.37M
98.94%2.79M
69.24%7.18M
42.10%4.54M
72.74%2.86M
127.33%1.4M
246.16%4.24M
343.03%3.2M
156.71%1.66M
-Interest Income (Financial expense)
42.84%-1.1M
40.07%-902.99K
34.04%-514.64K
33.60%-2.55M
24.18%-1.93M
-46.96%-1.51M
-103.61%-780.19K
-170.59%-3.85M
-162.13%-2.54M
-235.38%-1.03M
Research and development
23.82%99.4M
81.12%75.29M
155.99%47.74M
-5.95%114.73M
14.42%80.28M
31.76%41.57M
13.89%18.65M
116.45%121.99M
110.61%70.16M
38.90%31.55M
Credit Impairment Loss
-69.54%-15.59M
-30.49%-21.91M
-35.33%2.64M
87.10%-1.59M
18.85%-9.2M
-11.87%-16.79M
184.21%4.08M
-35.89%-12.3M
-65.41%-11.33M
-89.03%-15.01M
Asset Impairment Loss
124.08%5.07M
304.13%5.41M
236.42%6.23M
-19.96%-4.73M
1,586.33%2.26M
198.06%1.34M
-1,579.30%-4.57M
-421.91%-3.94M
-95.86%134.28K
-144.78%-1.37M
Other net revenue
Invest income
-50.80%500.63K
-72.25%178.89K
-97.11%18.66K
-71.85%1.04M
-70.93%1.02M
-81.17%644.73K
77.54%644.73K
-1.68%3.7M
512.21%3.5M
3,866.82%3.42M
Asset deal income
----
----
----
-1.70%-149.54K
-1.70%-149.54K
-46.41%-149.83K
----
-206.88%-147.05K
---147.05K
---102.34K
Other revenue
36.85%3.7M
503.97%2.81M
161.89%1.13M
-86.88%3.25M
494.84%2.71M
-44.20%464.79K
136.85%431.11K
525.31%24.8M
-86.75%454.86K
-63.75%833.02K
Operating profit
-97.41%519.95K
-242.56%-31.74M
-845.36%-28.31M
-92.55%3.1M
-57.86%20.1M
-34.95%22.27M
160.13%3.8M
-59.03%41.62M
-34.00%47.68M
-14.67%34.23M
Add:Non operating Income
-89.35%1.04M
-88.43%1.04M
556,245.58%1.04M
389.51%12.55M
247.11%9.8M
292.68%9M
-99.57%186.79
-54.47%2.56M
-48.07%2.82M
2.52%2.29M
Less:Non operating expense
406.63%116.87K
-16.22%16.76K
--24.44K
-93.96%32.12K
-95.66%23.07K
-96.24%20K
----
2,177.18%531.69K
4,329.58%531.69K
16,719,742.77%531.69K
Total profit
-95.16%1.45M
-198.31%-30.72M
-818.61%-27.3M
-64.22%15.62M
-40.22%29.88M
-13.18%31.25M
155.82%3.8M
-59.28%43.65M
-35.66%49.98M
-15.02%35.99M
Less:Income tax cost
-59.99%1.53M
----
----
-75.54%4.18M
-60.98%3.82M
-2.97%4.8M
--1.45M
2,306.64%17.07M
--9.8M
--4.95M
Net profit
-100.32%-82.91K
-216.16%-30.72M
-1,262.25%-27.3M
-56.95%11.44M
-35.16%26.05M
-14.81%26.44M
134.51%2.35M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
Net profit from continuing operation
-100.32%-82.91K
-216.16%-30.72M
-1,262.25%-27.3M
-56.95%11.44M
-35.16%26.05M
-14.81%26.44M
134.51%2.35M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
Less:Minority Profit
2.90%-4.11M
-31.92%-2.77M
13.70%-1.3M
---6.11M
---4.23M
---2.1M
---1.51M
----
----
----
Net profit of parent company owners
-86.71%4.03M
-197.90%-27.95M
-774.61%-26M
-33.94%17.56M
-24.62%30.28M
-8.04%28.55M
156.63%3.85M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
Earning per share
Basic earning per share
-86.75%0.0099
-197.87%-0.0689
-774.74%-0.0641
-33.99%0.0433
-24.62%0.0747
-8.09%0.0704
156.55%0.0095
-76.60%0.0656
-51.73%0.0991
-34.02%0.0766
Diluted earning per share
-86.75%0.0099
-197.87%-0.0689
-774.74%-0.0641
-33.99%0.0433
-24.62%0.0747
-8.09%0.0704
156.55%0.0095
-76.60%0.0656
-51.73%0.0991
-34.02%0.0766
Other composite income
Total composite income
-100.32%-82.91K
-216.16%-30.72M
-1,262.25%-27.3M
-56.95%11.44M
-35.16%26.05M
-14.81%26.44M
134.51%2.35M
-75.38%26.58M
-48.27%40.18M
-26.71%31.04M
Total composite income of parent company owners
-86.71%4.03M
-197.90%-27.95M
-774.61%-26M
-33.94%17.56M
-24.62%30.28M
-8.04%28.55M
156.63%3.85M
-75.38%26.58M
-48.27%40.18M
--31.04M
Total composite income of minority owners
2.90%-4.11M
-31.92%-2.77M
13.70%-1.3M
---6.11M
---4.23M
---2.1M
---1.51M
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.75%386.65M-2.97%226.28M5.87%70.8M-9.38%496.12M-4.98%352.3M0.21%233.2M24.91%66.87M12.38%547.48M30.20%370.78M37.60%232.71M
Operating revenue 9.75%386.65M-2.97%226.28M5.87%70.8M-9.38%496.12M-4.98%352.3M0.21%233.2M24.91%66.87M12.38%547.48M30.20%370.78M37.60%232.71M
Total operating cost 15.50%379.82M24.47%244.5M71.43%109.13M-5.24%490.85M4.16%328.85M5.47%196.44M3.41%63.66M34.39%517.97M48.28%315.7M47.24%186.25M
Operating cost -18.54%20.43M-24.15%12.3M-25.14%5.36M-18.09%32M-7.78%25.07M-7.07%16.22M146.53%7.16M32.05%39.06M28.02%27.19M41.80%17.45M
Operating tax surcharges 6.43%2.23M-4.17%1.6M3.60%402.43K-6.41%3.32M-6.08%2.09M1.31%1.67M17.89%388.44K10.67%3.55M23.76%2.23M23.15%1.65M
Operating expense 15.55%185.24M0.52%102.82M-14.35%23.92M-10.61%257.81M-5.07%160.31M-0.98%102.29M1.71%27.93M17.47%288.39M38.38%168.87M55.23%103.3M
Administration expense 8.40%63.04M41.57%46.87M231.47%29.43M23.01%78.31M25.85%58.16M5.23%33.11M-37.30%8.88M25.26%63.66M33.74%46.21M35.94%31.47M
Financial expense 223.52%9.48M255.47%5.62M247.42%2.28M257.23%4.68M181.32%2.93M89.18%1.58M98.56%655.18K2,286.90%1.31M3,793.86%1.04M90.11%835.37K
-Interest expense (Financial expense) 128.58%10.38M122.95%6.37M98.94%2.79M69.24%7.18M42.10%4.54M72.74%2.86M127.33%1.4M246.16%4.24M343.03%3.2M156.71%1.66M
-Interest Income (Financial expense) 42.84%-1.1M40.07%-902.99K34.04%-514.64K33.60%-2.55M24.18%-1.93M-46.96%-1.51M-103.61%-780.19K-170.59%-3.85M-162.13%-2.54M-235.38%-1.03M
Research and development 23.82%99.4M81.12%75.29M155.99%47.74M-5.95%114.73M14.42%80.28M31.76%41.57M13.89%18.65M116.45%121.99M110.61%70.16M38.90%31.55M
Credit Impairment Loss -69.54%-15.59M-30.49%-21.91M-35.33%2.64M87.10%-1.59M18.85%-9.2M-11.87%-16.79M184.21%4.08M-35.89%-12.3M-65.41%-11.33M-89.03%-15.01M
Asset Impairment Loss 124.08%5.07M304.13%5.41M236.42%6.23M-19.96%-4.73M1,586.33%2.26M198.06%1.34M-1,579.30%-4.57M-421.91%-3.94M-95.86%134.28K-144.78%-1.37M
Other net revenue
Invest income -50.80%500.63K-72.25%178.89K-97.11%18.66K-71.85%1.04M-70.93%1.02M-81.17%644.73K77.54%644.73K-1.68%3.7M512.21%3.5M3,866.82%3.42M
Asset deal income -------------1.70%-149.54K-1.70%-149.54K-46.41%-149.83K-----206.88%-147.05K---147.05K---102.34K
Other revenue 36.85%3.7M503.97%2.81M161.89%1.13M-86.88%3.25M494.84%2.71M-44.20%464.79K136.85%431.11K525.31%24.8M-86.75%454.86K-63.75%833.02K
Operating profit -97.41%519.95K-242.56%-31.74M-845.36%-28.31M-92.55%3.1M-57.86%20.1M-34.95%22.27M160.13%3.8M-59.03%41.62M-34.00%47.68M-14.67%34.23M
Add:Non operating Income -89.35%1.04M-88.43%1.04M556,245.58%1.04M389.51%12.55M247.11%9.8M292.68%9M-99.57%186.79-54.47%2.56M-48.07%2.82M2.52%2.29M
Less:Non operating expense 406.63%116.87K-16.22%16.76K--24.44K-93.96%32.12K-95.66%23.07K-96.24%20K----2,177.18%531.69K4,329.58%531.69K16,719,742.77%531.69K
Total profit -95.16%1.45M-198.31%-30.72M-818.61%-27.3M-64.22%15.62M-40.22%29.88M-13.18%31.25M155.82%3.8M-59.28%43.65M-35.66%49.98M-15.02%35.99M
Less:Income tax cost -59.99%1.53M---------75.54%4.18M-60.98%3.82M-2.97%4.8M--1.45M2,306.64%17.07M--9.8M--4.95M
Net profit -100.32%-82.91K-216.16%-30.72M-1,262.25%-27.3M-56.95%11.44M-35.16%26.05M-14.81%26.44M134.51%2.35M-75.38%26.58M-48.27%40.18M-26.71%31.04M
Net profit from continuing operation -100.32%-82.91K-216.16%-30.72M-1,262.25%-27.3M-56.95%11.44M-35.16%26.05M-14.81%26.44M134.51%2.35M-75.38%26.58M-48.27%40.18M-26.71%31.04M
Less:Minority Profit 2.90%-4.11M-31.92%-2.77M13.70%-1.3M---6.11M---4.23M---2.1M---1.51M------------
Net profit of parent company owners -86.71%4.03M-197.90%-27.95M-774.61%-26M-33.94%17.56M-24.62%30.28M-8.04%28.55M156.63%3.85M-75.38%26.58M-48.27%40.18M-26.71%31.04M
Earning per share
Basic earning per share -86.75%0.0099-197.87%-0.0689-774.74%-0.0641-33.99%0.0433-24.62%0.0747-8.09%0.0704156.55%0.0095-76.60%0.0656-51.73%0.0991-34.02%0.0766
Diluted earning per share -86.75%0.0099-197.87%-0.0689-774.74%-0.0641-33.99%0.0433-24.62%0.0747-8.09%0.0704156.55%0.0095-76.60%0.0656-51.73%0.0991-34.02%0.0766
Other composite income
Total composite income -100.32%-82.91K-216.16%-30.72M-1,262.25%-27.3M-56.95%11.44M-35.16%26.05M-14.81%26.44M134.51%2.35M-75.38%26.58M-48.27%40.18M-26.71%31.04M
Total composite income of parent company owners -86.71%4.03M-197.90%-27.95M-774.61%-26M-33.94%17.56M-24.62%30.28M-8.04%28.55M156.63%3.85M-75.38%26.58M-48.27%40.18M--31.04M
Total composite income of minority owners 2.90%-4.11M-31.92%-2.77M13.70%-1.3M---6.11M---4.23M---2.1M---1.51M------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership)------Zhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data